Medical Marijuana, Inc. Subsidiary Kannaway® Announces July 25, 2017 Largest Revenue Day in Company History

05:04 EDT 1 Aug 2017 | PR Newswire

SAN DIEGO, Aug. 1, 2017 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, today announced that its subsidiary Kannaway® achieved the largest revenue in a single day on July 25, 2017, in the Company's history. Kannaway® is the first hemp lifestyle network to offer cannabidiol (CBD) hemp botanical products.

"Kannaway®'s revenue has grown steeply beginning March 2016 to date. Kannaway® celebrated the largest revenue month in its history in June, and we believe July revenues will surpass our June performance," said Kannaway® CEO Blake Schroeder. "We look forward to setting new revenue performance records as our company continues to grow and enter new markets. We are especially excited about Kannaway®'s European expansion set for Q4, 2017."  

Recognizing that the success of Kannaway® brand ambassadors is a key part of the Company's mission, the Company has initiated several programs to recognize top performers that include special trip and prize incentives and an innovative stock incentive program.

For more information on Kannaway®, click HERE to visit the Company website.

About Kannaway, LLC
Kannaway, LLC is a network sales and marketing company specializing in the sales and marketing of hemp-based botanical products. Kannaway currently hosts weekly online sales meetings and conferences across the United States, offering unique insight and opportunity to sales professionals who are desirous of becoming successful leaders in the sale and marketing of hemp-based botanical products.

About Medical Marijuana, Inc.We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.'s portfolio and investment companies, visit

To see Medical Marijuana, Inc.'s video statement, click here.

Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.


This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.

The statements in this press release have not been evaluated by the Food and Drug Administration (FDA) and are not intended to diagnose, treat or cure any disease.  The Company does not sell or distribute any products that are in violation of the United States Controlled Substances Act. The Company does sell and distribute hemp-based products.

CONTACT:Public Relations Contact: Andrew Hard
Chief Executive Officer
CMW Media
P: 888-829- 0070

View original content:

SOURCE Medical Marijuana, Inc.


More From BioPortfolio on "Medical Marijuana, Inc. Subsidiary Kannaway® Announces July 25, 2017 Largest Revenue Day in Company History"

Quick Search

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...